Companies · Other Health Care

Tegria RCM Group - US, Inc.

RENTON · Other Health Care

Diligence memoA one-page analyst read on Tegria RCM Group - US, Inc. — recommendation, valuation, rhythm, risks.
$11.8M
Total raised · real
3
Rounds
0.0×
Latest step-up
Top 23%
Sector rank · raised
Series A
Latest stage · inferred · Fri Sep 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Tegria RCM Group - US, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.06× the median modeled value of Series A Other Health Care companies in 2022–2024 (196 peers) — value vs value, same stage and era.
At-risk
  • Last raise 3.8 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Tegria RCM Group - US, Inc. is one of 5377 Other Health Care companies tracked from RENTON. By capital raised it ranks in the upper tier (ahead of 78% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2021
Year incorporated
2022-09-30
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeries A · 2021-09-13 Raised $6.7M (real) Modeled valuation $88M (est)$6.7M$88MSeries A2021Series A · 2021-10-04 Raised $4.8M (real) Modeled valuation $62M (est)$4.8M$62MSeries A2021Series A · 2022-09-30 Raised $227K (real) Modeled valuation $2.0M (est)$227K$2.0MSeries A2022+$4.8M+$227KCumulative $12M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.7M · 2021
Series A extension$4.8M · 2021
Series A extension$227K · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$2.0M
Base estimate est.
$291K
Conservative case
$6.6M
Upside case
$1.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $88.3M · 2021-09-132021Series A · modeled $62.3M · 2021-10-04Series A · modeled $2.0M · 2022-09-302022
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
3.8 yr
Elapsed time used
3.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$11.3M/yr
Capital velocity
4.8 yr
On record since
2021
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 4.9× above median
This company$11.8M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.0× of median
This company$227K
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$2.0M
Sector median$22.1M

Raised more than 78% of sector peers (real $). Modeled value above 10% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #190 of 196.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)CareHarmony, Inc. · Series A Raised $17.4M · modeled $145.2M (est)Dragonfly Endoscopy Inc. · Series A Raised $12.7M · modeled $142.0M (est)NuvoAir Holdings, Inc. · Series A Raised $10.7M · modeled $125.1M (est)Post Acute Recovery, Inc. · Series A Raised $14.5M · modeled $123.0M (est)Micro Interventional Devices, Inc. · Series A Raised $14.0M · modeled $119.0M (est)Etiometry Inc. · Series A Raised $15.6M · modeled $114.7M (est)SafKan, Inc. · Series A Raised $13.0M · modeled $108.5M (est)BehaVR Holdings, Inc. · Series A Raised $12.1M · modeled $102.1M (est)Outliers Inc. · Series A Raised $13.6M · modeled $101.7M (est)RevMedica, Inc. · Series A Raised $14.2M · modeled $101.2M (est)Innovoyce LLC · Series A Raised $9.9M · modeled $97.6M (est)Prixz, Inc. · Series A Raised $9.2M · modeled $97.4M (est)Tegria RCM Group - US, Inc. (this company) Raised $11.8M · modeled $2.0M (est)Tegria RCM Group - US, Inc.
CompanyStageRaised · realValue · estvs peer med.
CareHarmony, Inc.Series A$17.4M$145.2M3.96×
Dragonfly Endoscopy Inc.Series A$12.7M$142.0M3.87×
NuvoAir Holdings, Inc.Series A$10.7M$125.1M3.41×
Post Acute Recovery, Inc.Series A$14.5M$123.0M3.35×
Micro Interventional Devices, Inc.Series A$14.0M$119.0M3.25×
Etiometry Inc.Series A$15.6M$114.7M3.13×
SafKan, Inc.Series A$13.0M$108.5M2.96×
BehaVR Holdings, Inc.Series A$12.1M$102.1M2.78×
Outliers Inc.Series A$13.6M$101.7M2.77×
RevMedica, Inc.Series A$14.2M$101.2M2.76×
Innovoyce LLCSeries A$9.9M$97.6M2.66×
Prixz, Inc.Series A$9.2M$97.4M2.66×
Tegria RCM Group - US, Inc. this companySeries A$11.8M$2.0M0.06×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.7M2021-09-13$30.6M$88.3M90%
Series A$4.8M2021-10-04$22.0M$62.3M90%
Series A$227K2022-09-30$1.0M$2.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.7M2021-09-13
    • First recorded raise — entered as Series A.
    • 11 investors on this round.
  2. Series A$4.8M2021-10-04
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  3. Series A$227K2022-09-30
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 21.4× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2023 ~Q2
Modeled next raise · ~6mo cadence
$227K
Modeled next size est.range $227K$363K
0.0×
Last step-up
$11.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Whipple1 other2021-09
Paul George1 other2021-09
Dan Rieber2021-09
Kevin Manemann2021-09
Lincoln Popp2021-09
Sandra Andrews2021-09
Registry & provenance

Tegria RCM Group - US, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1883671
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Tegria Services Group, Inc.Other Health CareSeries A$10.8M$7.6Mnetwork2 shared operators · same sector · same stage
Wellist, Inc.Other Health CareSeries A$12.8M$1.3Msame sector · same stage
Assure Holdings Corp.Other Health CareSeries A$13.1M$2.6Msame sector · same stage
RF Surgical Systems, IncOther Health CareSeries A$14.6M$2.4Msame sector · same stage
Theravida, Inc.Other Health CareSeries A$9.1M$1.6Msame sector · same stage
South Campus Surgery Center LlcOther Health CareSeries A$15.3M$1.8Msame sector · same stage
Inspire Veterinary Partners, Inc.Other Health CareSeries A$8.9M$1.2Msame sector · same stage
Momtech Inc.Other Health CareSeries A$7.9M$2.2Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Tegria Services Group, Inc.Other Health CareSeries A$7.6M95%
tEMed Holdings LLCOther Health CareSeries A$121.1M86%
TegoSens, Inc.Other Health CareSeed$35.5M86%
Teckro, Inc.Other Health CareSeries B$366.4M85%
Tetricus Inc.Other Health CarePre-Seed$2.7M84%
MedVirginia, Inc.Other Health CareSeed$12.4M84%
TecTraum, Inc.Other Health CareSeed$36.7M83%
TETmedical, Inc.Other Health CareSeed$17.5M83%
Frequently asked
How much funding has Tegria RCM Group - US, Inc. raised?
Tegria RCM Group - US, Inc. has raised approximately $11.8M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Tegria RCM Group - US, Inc.'s estimated valuation?
Provath's modeled valuation for Tegria RCM Group - US, Inc. is approximately $2.0M (modeled range $291K–$6.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Tegria RCM Group - US, Inc. at?
Tegria RCM Group - US, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Sep 30.
What does Tegria RCM Group - US, Inc. do and where is it based?
Tegria RCM Group - US, Inc. operates in the Other Health Care sector, based in RENTON.
Explore related

See where Tegria RCM Group - US, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Tegria RCM Group - US, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.